Dr. Evdokia Anagnostou is a child Neurologist and clinician scientist at Bloorview Research Institute. Dr. Anagnostou's research focuses on the psychopharmacology and neuroimaging of autism. Dr. Anagnostou is principal or co-investigator on multiple clinical trials in autism and has had extensive funding in both pharmacology and neuroimaging. She leads the Ontario Brain Institute funded POND grant that embeds a clinical trial network in biomarkers core for ASD, ADHD, ID and OCD.
She is also the Co-Director of the Autism Research Centre at Holland Bloorview. Her research at Holland Bloorview focuses on the development of clinical trials to test novel compounds for the treatment of autism and related disorders. In collaboration with imaging researchers at SickKids, she is also studying the developmental trajectory of abnormalities in the frontostriatal circuitry in autism, and exploring the mechanisms of treatment response and side effects generation using fMRI, MR spectroscopy and DTI techniques.